Should Monitoring of Fibroblast Growth Factor-23 Levels in Dialysis Patients Be a Part of Routine Clinical Practice?

2014 ◽  
Vol 27 (6) ◽  
pp. 565-568
Author(s):  
Georges Saab ◽  
Mildred Lam ◽  
Sankar D Navaneethan ◽  
Eduardo Slatopolsky
Keyword(s):  
Clinical Practice ◽  
Growth Factor ◽  
Fibroblast Growth Factor ◽  
Fibroblast Growth Factor 23 ◽  
Routine Clinical Practice ◽  
Fibroblast Growth ◽  
Dialysis Patients

Fibroblast growth factor 23 is associated with left ventricular hypertrophy, not with uremic vasculopathy in peritoneal dialysis patients

2016 ◽  
Vol 85 (2016) (03) ◽  
pp. 135-141 ◽  
Author(s):  
Margarida Sarmento-Dias ◽  
Carla Santos-Araújo ◽  
Rui Poínhos ◽  
Bruno Oliveira ◽  
Isabell Soares Silva ◽  
...  
Keyword(s):  
Peritoneal Dialysis ◽  
Growth Factor ◽  
Left Ventricular Hypertrophy ◽  
Fibroblast Growth Factor ◽  
Ventricular Hypertrophy ◽  
Fibroblast Growth Factor 23 ◽  
Left Ventricular ◽  
Fibroblast Growth ◽  
Dialysis Patients
Sign in / Sign up

Export Citation Format

Share Document